Joseph Rubinfeld

Joseph Rubinfeld is the founder of Amgen, Inc. (1980), SuperGen, Inc. (1991), and Vivacitas Oncology, Inc. (2015).
He held the title of Chief Operating Officer & Vice President at Amgen, Inc. and Director & Chief Scientific Officer at SuperGen, Inc. Dr. Rubinfeld is also the founder of Imcure Therapeutics, Inc. He held former positions as Vice Chairman at Quark Pharmaceuticals, Inc., Independent Director at LadRx Corp.
(2012-2016), Director at Sarepta Therapeutics, Inc., Director at Regenicin, Inc. (2010-2016), Senior Director at Cetus Corp.
(1968-1980), Independent Director at Amarantus Bioscience Holdings, Inc. (2014-2016), Research Scientist at Colgate-Palmolive Co., and Research Scientist at Schering-Plough Corp.
Dr. Rubinfeld received his graduate and doctorate degrees from The Trustees of Columbia University in The City of New York and his undergraduate degree from The City College of New York.